What is Granata Bio worth?
$129.0Mlast known valuation
Granata Bio last raised $13.8M in its Early Stage VC (Dec 2024).
Free account
See the evidence behind this price
- ·Post-money valuations for all 2 rounds
- ·The complete investor list — 9 names
- ·Watchlist + deal alerts for Granata Bio
Create free account
No card required
Funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2024 | Early Stage VC | $13.8M | ▮ | ▮ |
| Oct 2023 | Early Stage VC | $10.1M | ▮ | ▮ |
How Granata Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Granata Bio, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Granata Bio worth?
- Granata Bio's last known valuation is $129.0M.
- How much has Granata Bio raised?
- Granata Bio has raised $31.1M in total funding across 2 recorded rounds.
- When did Granata Bio last raise?
- Granata Bio last raised in Dec 2024 (Early Stage VC), raising $13.8M.